Kala Pharmaceuticals Inc (KALA) Stock Analysis

Kala Pharmaceuticals Inc (KALA) is a publicly traded company in the HEALTHCARE sector. It trades at $2.39, carries a market capitalization of $42.57M. This page summarizes the public market data, fundamentals, and frequently asked questions for KALA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Kala Pharmaceuticals Inc currently has a Bearish sentiment score of -0.48.

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc, based in Watertown, Massachusetts, is a forward-thinking biopharmaceutical company focused on the discovery, development, and commercialization of cutting-edge therapies for ocular conditions. Leveraging its proprietary nanoparticle-based mucus penetrating particle (MPP) technology, Kala aims to significantly enhance drug delivery and therapeutic effectiveness in ophthalmic care. By prioritizing innovative solutions for eye diseases, the company is strategically posi...

GNG Research Analysis

GNG Research scores Kala Pharmaceuticals Inc (KALA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KALA.

Frequently Asked Questions

Does KALA pay dividends?

Kala Pharmaceuticals Inc (KALA) does not currently pay a regular dividend.

What is KALA's market cap?

Kala Pharmaceuticals Inc (KALA) has a market capitalization of $42.57M with a current stock price of $2.39.